Impact of guideline changes on adoption of hypofractionation and breast cancer patient characteristics in the randomized controlled HYPOSIB trial

por Krug, David, Vonthein, Reinhard, Schreiber, Andreas, Boicev, Alexander D., Zimmer, Jörg, Laubach, Reinhold, Weidner, Nicola, Dinges, Stefan, Hipp, Matthias, Schneider, Ralf, Weinstrauch, Evelyn, Martin, Thomas, Hörner-Rieber, Juliane, Olbrich, Denise, Illen, Alicia, Heßler, Nicole, König, Inke R., Dellas, Kathrin, Dunst, Jürgen
Publicado 2020